CA2148112A1 - New pharmaeutical dosage form for transdermal administration - Google Patents
New pharmaeutical dosage form for transdermal administrationInfo
- Publication number
- CA2148112A1 CA2148112A1 CA2148112A CA2148112A CA2148112A1 CA 2148112 A1 CA2148112 A1 CA 2148112A1 CA 2148112 A CA2148112 A CA 2148112A CA 2148112 A CA2148112 A CA 2148112A CA 2148112 A1 CA2148112 A1 CA 2148112A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaeutical
- new
- dosage form
- transdermal administration
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002552 dosage form Substances 0.000 title 1
- 229940124532 absorption promoter Drugs 0.000 abstract 1
- 239000002998 adhesive polymer Substances 0.000 abstract 1
- 229920001296 polysiloxane Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a composition intended to form a film on the skin for the transdermal adminis-tration of an active principle, which comprises:
a) a lipophilic active principle b) from 5 to 60 % by weight of a silicone-based adhesive polymer composition c) from 0 to 25 % by weight of an absorption promoter, and d) from 25 to 95 % by weight of a volatile solvent.
a) a lipophilic active principle b) from 5 to 60 % by weight of a silicone-based adhesive polymer composition c) from 0 to 25 % by weight of an absorption promoter, and d) from 25 to 95 % by weight of a volatile solvent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9405272A FR2719220A1 (en) | 1994-04-29 | 1994-04-29 | New galenic form for transdermal administration. |
FR9405272 | 1994-04-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2148112A1 true CA2148112A1 (en) | 1995-10-30 |
CA2148112C CA2148112C (en) | 2001-01-30 |
Family
ID=9462709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002148112A Expired - Fee Related CA2148112C (en) | 1994-04-29 | 1995-04-27 | New pharmaeutical dosage form for transdermal administration |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0679392B1 (en) |
JP (1) | JP2740465B2 (en) |
KR (1) | KR100233770B1 (en) |
AT (1) | ATE210430T1 (en) |
AU (1) | AU680731B2 (en) |
CA (1) | CA2148112C (en) |
DE (1) | DE69524470T2 (en) |
DK (1) | DK0679392T3 (en) |
ES (1) | ES2169746T3 (en) |
FR (1) | FR2719220A1 (en) |
HK (1) | HK1008658A1 (en) |
HU (1) | HU221599B (en) |
NZ (1) | NZ272014A (en) |
PT (1) | PT679392E (en) |
TW (1) | TW448050B (en) |
ZA (1) | ZA953392B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2740038B1 (en) * | 1995-10-20 | 1998-01-02 | Lafon Labor | COMPOSITION FOR TRANSDERMAL ADMINISTRATION |
DE69717847T2 (en) * | 1996-10-24 | 2003-09-18 | The Procter & Gamble Company, Cincinnati | SKIN ODOR REDUCTION COMPOSITIONS |
US5968919A (en) * | 1997-10-16 | 1999-10-19 | Macrochem Corporation | Hormone replacement therapy drug formulations for topical application to the skin |
DE19830732B4 (en) * | 1998-07-09 | 2008-11-13 | Lts Lohmann Therapie-Systeme Ag | Composition containing at least one substance influencing blood lipid levels and its use |
US6512072B1 (en) | 2000-06-12 | 2003-01-28 | Dow Corning Corporation | Fast cure film forming formulation |
FR2827764B1 (en) * | 2001-07-27 | 2005-08-19 | Oreal | COMPOSITION, IN PARTICULAR COSMETIC, CONTAINING A STEROID AND A GLYCOL |
ATE388697T1 (en) * | 2003-11-21 | 2008-03-15 | Galderma Res & Dev | SPRAYABLE COMPOSITION FOR ADMINISTRATION OF VITAMIN D DERIVATIVES |
FR2867682B1 (en) * | 2004-03-22 | 2009-06-05 | Galderma Res & Dev | ANHYDROUS PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND A SOLUBILIZED ACTIVE INGREDIENT. |
KR20070027587A (en) * | 2004-06-17 | 2007-03-09 | 갈데르마 소시에떼아노님 | Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
FR2871695B1 (en) | 2004-06-17 | 2008-07-04 | Galderma Sa | PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE INGREDIENTS |
FR2887150B1 (en) * | 2005-06-17 | 2007-08-03 | Galderma Res & Dev | PHARMACEUTICAL COMPOSITION COMPRISING AN ORGANOPOLYSILOXANE ELASTOMER AND A SOLUBILIZED ACTIVE INGREDIENT |
FR2909284B1 (en) * | 2006-11-30 | 2012-09-21 | Galderma Sa | NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
JP6105494B2 (en) | 2011-03-14 | 2017-03-29 | ドラッグ デリバリー ソリューションズ リミテッド | Ophthalmic composition |
US20130323332A1 (en) * | 2012-05-31 | 2013-12-05 | Sherry May Raymond-Coblantz | Hand and body moisturizing serum |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3836647A (en) * | 1970-10-22 | 1974-09-17 | Dow Corning | Wash-resistant skin preparation |
DE2140491A1 (en) * | 1971-08-12 | 1973-02-22 | Pawlowa | Bactericidal compsns - contg a quaternary base, a filmogenic polymer and a solvent |
US4584192A (en) * | 1984-06-04 | 1986-04-22 | Minnesota Mining & Manufacturing Company | Film-forming composition containing an antimicrobial agent and methods of use |
EP0289900A1 (en) * | 1987-04-30 | 1988-11-09 | Abbott Laboratories | Topical antibacterial compositions |
JPH02145512A (en) * | 1988-11-26 | 1990-06-05 | Shin Etsu Chem Co Ltd | External preparation of film forming type |
IN172390B (en) * | 1989-07-18 | 1993-07-10 | Ethicon Inc | |
DE69007886T2 (en) * | 1989-07-21 | 1994-11-17 | Izhak Blank | Oestradiol containing agents and methods for topical use. |
TW247878B (en) * | 1991-07-02 | 1995-05-21 | Takeda Pharm Industry Co Ltd | |
GB9114346D0 (en) * | 1991-07-03 | 1991-08-21 | Dow Corning Sa | A method of accelerating drug permeation |
EP0560014A1 (en) * | 1992-03-12 | 1993-09-15 | Atrix Laboratories, Inc. | Biodegradable film dressing and method for its formation |
-
1994
- 1994-04-29 FR FR9405272A patent/FR2719220A1/en active Granted
-
1995
- 1995-04-26 ES ES95400949T patent/ES2169746T3/en not_active Expired - Lifetime
- 1995-04-26 ZA ZA953392A patent/ZA953392B/en unknown
- 1995-04-26 EP EP95400949A patent/EP0679392B1/en not_active Expired - Lifetime
- 1995-04-26 DE DE69524470T patent/DE69524470T2/en not_active Expired - Fee Related
- 1995-04-26 DK DK95400949T patent/DK0679392T3/en active
- 1995-04-26 PT PT95400949T patent/PT679392E/en unknown
- 1995-04-26 AT AT95400949T patent/ATE210430T1/en not_active IP Right Cessation
- 1995-04-27 CA CA002148112A patent/CA2148112C/en not_active Expired - Fee Related
- 1995-04-28 NZ NZ272014A patent/NZ272014A/en unknown
- 1995-04-28 JP JP7106274A patent/JP2740465B2/en not_active Expired - Fee Related
- 1995-04-28 HU HU9501245A patent/HU221599B/en not_active IP Right Cessation
- 1995-04-28 AU AU17675/95A patent/AU680731B2/en not_active Ceased
- 1995-04-28 KR KR1019950010376A patent/KR100233770B1/en not_active IP Right Cessation
- 1995-06-14 TW TW084106070A patent/TW448050B/en not_active IP Right Cessation
-
1998
- 1998-07-02 HK HK98108827A patent/HK1008658A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1767595A (en) | 1995-11-16 |
NZ272014A (en) | 1997-05-26 |
AU680731B2 (en) | 1997-08-07 |
FR2719220B1 (en) | 1997-02-14 |
HUT75251A (en) | 1997-05-28 |
ATE210430T1 (en) | 2001-12-15 |
PT679392E (en) | 2002-05-31 |
KR100233770B1 (en) | 1999-12-01 |
HU9501245D0 (en) | 1995-06-28 |
TW448050B (en) | 2001-08-01 |
DE69524470T2 (en) | 2002-05-23 |
EP0679392B1 (en) | 2001-12-12 |
ZA953392B (en) | 1996-10-28 |
FR2719220A1 (en) | 1995-11-03 |
HK1008658A1 (en) | 1999-05-14 |
JPH0859456A (en) | 1996-03-05 |
ES2169746T3 (en) | 2002-07-16 |
EP0679392A1 (en) | 1995-11-02 |
CA2148112C (en) | 2001-01-30 |
DK0679392T3 (en) | 2002-04-08 |
KR950028767A (en) | 1995-11-22 |
DE69524470D1 (en) | 2002-01-24 |
JP2740465B2 (en) | 1998-04-15 |
HU221599B (en) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2148112A1 (en) | New pharmaeutical dosage form for transdermal administration | |
CA2153572A1 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
ITMI961152A0 (en) | THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE INGREDIENT, ESTROGEN OR PROGESTIN OR MIXTURES THEREOF | |
CA2004598A1 (en) | Medicinal aerosol formulations | |
HUP9802983A2 (en) | Transdermal delivery system comprising silicone derivatives | |
ATA189395A (en) | ORAL PHARMACEUTICAL PREPARATION | |
WO2002045699A3 (en) | Transdermal therapeutic system comprising the active ingredient oxybutynin | |
MY109939A (en) | Patches for percutaneous administration of skin- whitening materials | |
IT8921118A0 (en) | COMPOSITION FOR AEROSOL INCLUDING NITROGLYCERIN AS THE ACTIVE INGREDIENT. | |
AU632182B2 (en) | Transdermal therapeutic system comprising as active component buprenorphine | |
AU4877090A (en) | Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances | |
NO895172L (en) | PROCEDURE FOR THE PREPARATION OF A TRANSDERMAL THERAPEUTIC SYSTEM WITH PHYTOSTIGMIN AS A SUBSTANCE. | |
EP0900565A4 (en) | Patch containing isosorbide dinitrate | |
EP0380989A3 (en) | Plaster for transdermal administration | |
EP0378413A3 (en) | Compositions for topical treatment of skin disorders | |
AU4684389A (en) | Transdermal therapeutic system comprising norpseudoephedrine as active component | |
CA2370023A1 (en) | Transdermal therapeutic system with a highly effective neuroleptic agent | |
ATE35620T1 (en) | PHARMACEUTICAL PREPARATION WITH RETARDED EFFECT. | |
CA2235346A1 (en) | Composition for transdermal delivery | |
FR2694292B1 (en) | Benzimidazole-2-thione- derivatives, their preparation and their use as medicaments. | |
AU1042888A (en) | Pain-killer | |
RU95118764A (en) | DRUG FOR TREATMENT OF PURULENT WASES ON THE BACKGROUND OF DIABETES MELLITUS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |